Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Rosenblatt Reiterates Buy on Universal Technical, Maintains $9 Price Target

Rosenblatt analyst Steve Frankel reiterates Universal Technical (NYSE:UTI) with a Buy and maintains $9 price target.

byBenzinga Newsdesk

February 9, 2023

1 minute read

Rosenblatt analyst Steve Frankel reiterates Universal Technical (NYSE:UTI) with a Buy and maintains $9 price target.

Analyst Ratings

Expert Ratings For PowerSchool Holdings

By Benzinga Insights

Today, 4:33 AM

PowerSchool Holdings (NYSE:PWSC) has observed the following analyst ratings within the last quarter:

PWSC

UNITY Biotech Offers Program Updates, Expected Milestones For 2022

By Benzinga Newsdesk

Today, 4:33 AM

12-week safety and efficacy analysis from a Phase 2 study of UBX1325 in diabetic macular edema (DME) expected in first half 2022 and wet age-related macular degeneration (wet AMD) expected in the second half of

UBX

Fleetcor Technologies Q2 EPS $3.15 Beats $2.92 Estimate, Sales $667.38M Beat $632.17M Estimate

By Benzinga Newsdesk

Today, 4:33 AM

Fleetcor Technologies (NYSE:FLT) reported quarterly earnings of $3.15 per share which beat the analyst consensus estimate of $2.92 by 7.88 percent. This is a 38.16 percent increase over earnings of $2.28 per share from

FLT

NextGen Healthcare Q1 EPS $0.16, Inline, Sales $153.30M Beat $152.90M Estimate

By Benzinga Newsdesk

Today, 4:33 AM

NextGen Healthcare (NASDAQ:NXGN) reported quarterly earnings of $0.16 per share which met the analyst consensus estimate. This is a 36 percent decrease over earnings of $0.25 per share from the same period last year.

NXGN

Rosenblatt Reiterates Buy on Universal Technical, Maintains $9 Price Target

Related Posts

Expert Ratings For PowerSchool Holdings

UNITY Biotech Offers Program Updates, Expected Milestones For 2022

Fleetcor Technologies Q2 EPS $3.15 Beats $2.92 Estimate, Sales $667.38M Beat $632.17M Estimate

NextGen Healthcare Q1 EPS $0.16, Inline, Sales $153.30M Beat $152.90M Estimate